PRL and neoplasm: In a review of 12 studies of 309 patients with macroprolactinomas, including giant prolactinomas, treatment with cabergoline (CAB) was accompanied by normalization of PRL in 80% and significant tumor reduction in 87% of the patients, thus demonstrating a good response to DA even in larger tumors (16).